Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Method for isolation & accumulation of small RNAs for clinical marker development

12.11.2012
A large part of gene regulation in eukaryotes takes place at the level of RNA-molecules. A group of endogenous regulatory RNA-molecules, the so-called microRNAs (miRNAs) appear to be involved in the regulation of about 30% of all human genes. These “small RNA” molecules (sRNA) also play a role in the development of diseases such as cancer, diabetes or neurological disorders. Disease-associated changes of miRNA expression patterns provide new prognostic and diagnostic opportunities and are qualified for the development of respective clinical markers.

To detect miRNA-derived biomarkers a whole-RNA purification from the sample has to be performed. For an identification of yet unknown miRNAs it is required to clone and sequence the purified sRNAs. In most cases miRNAs which are present in a sample at low concentrations are further depleted during the purification steps or even get lost, which renders in the results of the analysis non-representative and increases the risk to overlook potential biomarkers. The present invention is based on the finding, that the plant-viral protein ’Helper component proteinase’ (HC-Pro) can be used for a binding of sRNAs including miRNAs. Thus, HC-Pro can be used in order to enrich and to isolate sRNAs from samples. In addition a cupin protein was identified which clearly improves the binding of HC-Pro for sRNAs.

Further Information: PDF

IMG Innovations-Management GmbH
Phone: +49 (0)631/31668-50

Contact
Dr. Klaus Kobek

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=2122&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht Highly specific nucleases for gene targeting and gene therapy
01.07.2015 | TechnologieAllianz e.V.

nachricht New Furin Inhibitors for Treatment of Infectious Diseases
01.07.2015 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Viaducts with wind turbines, the new renewable energy source

Wind turbines could be installed under some of the biggest bridges on the road network to produce electricity. So it is confirmed by calculations carried out by a European researchers team, that have taken a viaduct in the Canary Islands as a reference. This concept could be applied in heavily built-up territories or natural areas with new constructions limitations.

The Juncal Viaduct, in Gran Canaria, has served as a reference for Spanish and British researchers to verify that the wind blowing between the pillars on this...

Im Focus: X-rays and electrons join forces to map catalytic reactions in real-time

New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions

A new technique pioneered at the U.S. Department of Energy's Brookhaven National Laboratory reveals atomic-scale changes during catalytic reactions in real...

Im Focus: Iron: A biological element?

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...

Im Focus: Thousands of Droplets for Diagnostics

Researchers develop new method enabling DNA molecules to be counted in just 30 minutes

A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of...

Im Focus: Bionic eye clinical trial results show long-term safety, efficacy vision-restoring implant

Patients using Argus II experienced significant improvement in visual function and quality of life

The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Conference on Regenerative Medicine in Leipzig: Last chance to submit abstracts until 2 July

25.06.2015 | Event News

World Conference on Regenerative Medicine: Abstract Submission has been extended to 24 June

16.06.2015 | Event News

MUSE hosting Europe’s largest science communication conference

11.06.2015 | Event News

 
Latest News

Siemens receives order for offshore wind power plant in Great Britain

03.07.2015 | Press release

'Déjà vu all over again:' Research shows 'mulch fungus' causes turfgrass disease

03.07.2015 | Agricultural and Forestry Science

Discovery points to a new path toward a universal flu vaccine

03.07.2015 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>